Academic Detailing for HIV Prevention
(ADOPT-PrEP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a method called academic detailing to determine if it helps pediatricians better prescribe HIV prevention medication, known as PrEP, to teens and young adults. Academic detailing involves trained educators having one-on-one conversations with doctors to encourage changes in medical practice. The trial aims to assess the practicality of this approach and its impact on how often doctors recommend PrEP and how patients use it. Pediatricians at specific Boston medical centers are the focus of this study. As an unphased trial, this study offers participants the chance to contribute to innovative educational methods that could enhance healthcare practices.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that this academic detailing technique is safe for pediatricians?
Research has shown that academic detailing is safe and well-tolerated. This approach involves one-on-one educational sessions to improve healthcare practices. Studies have found it effectively increases awareness and knowledge, particularly in areas like HIV prevention and treatment. As an educational method rather than a medication or medical procedure, it has no reported side effects, making it a low-risk option for participants.12345
Why are researchers excited about this trial?
Researchers are excited about academic detailing for HIV prevention because it offers a personalized approach to educating healthcare providers, like pediatricians, about the latest prevention strategies. Unlike standard educational materials or training sessions, academic detailing involves one-on-one interactions with experts who tailor the information to the specific needs and context of the healthcare provider. This method has the potential to improve the adoption of HIV prevention practices by making them more relevant and actionable for providers, ultimately enhancing patient care.
What evidence suggests that academic detailing is effective for changing pediatricians' prescribing behavior for HIV prevention?
Studies have shown that academic detailing effectively increases the prescribing of pre-exposure prophylaxis (PrEP) for HIV prevention. This approach involves personalized educational sessions that help doctors understand and use new treatments. Research indicates that academic detailing has improved routine HIV testing and awareness among healthcare providers. By enhancing knowledge and changing prescribing habits, academic detailing aims to make PrEP more accessible to those who need it. This method has succeeded in places like New York City and New England, leading to better care and prevention outcomes.13567
Are You a Good Fit for This Trial?
This trial is for primary care providers at Boston Children's Hospital Adolescent/Young Adult Medicine, Martha Eliot Health Center, or Children's Hospital Primary Care Center. There are no specific exclusion criteria mentioned.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Academic Detailing Intervention
Pediatric providers participate in academic detailing sessions to improve PrEP prescribing practices
Follow-up
Participants are monitored for changes in PrEP prescriptions, persistence, and HIV testing
What Are the Treatments Tested in This Trial?
Interventions
- Academic detailing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor